Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide

✍ Scribed by Jeremy D. Gates; Guy T. Clifton; Linda C. Benavides; Alan K. Sears; Mark G. Carmichael; Matthew T. Hueman; Jarrod P. Holmes; Yusuf H. Jama; Mohamed Mursal; Athina Zacharia; Kathy Ciano; Steven Khoo; Alexander Stojadinovic; Sathibalan Ponniah; George E. Peoples

• Book ID: 116963079
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 479 KB
• Volume: 28
• Category: Article
• ISSN: 0264-410X
• DOI: 10.1016/j.vaccine.2010.09.029